NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

May 22, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Breast Cancer
Interventions
PROCEDURE

Tumour bed core biopsy

Collection of up to 8 core biopsies across 4 zones of the whole tumour bed to detect residual cancer post neo-adjuvant treatment

Trial Locations (24)

SS16 5NL

Basildon Hospital, Basildon

Unknown

Belfast City Hospital, Belfast

Queen Elizabeth Hospital, Birmingham

Dumfries and Galloway Royal Infirmary, Dumfries

Western General, Edinburgh

Singleton Hospital, Swansea

B18 7QH

City Hospital, Birmingham

FY3 8NR

Blackpool Teaching Hospitals NHS Trust, Blackpool

BS10 5NB

Southmead Hospital, Bristol

CF64 2XX

University Hospital of Llandough, Cardiff

GL53 7AN

Cheltenham General Hospital, Cheltenham

HA1 3UJ

Northwick Park Hospital, Harrow

LS9 7TF

St James's University Hospital, Leeds

L7 8XP

Royal Liverpool Hospital, Liverpool

SW3 6JJ

Royal Marsden Hospital, London

TD6 9BS

Borders General Hospital, Melrose

NE1 4LP

Royal Victoria Infirmary, Newcastle upon Tyne

NG5 1PB

Nottingham City Hospital, Nottingham

PE3 9GZ

Peterborough City Hospital, Peterborough

BH15 2JB

Poole Hospital, Poole

S10 2SJ

Weston Park Hospital, Sheffield

SO16 6YD

Southampton General Hospital, Southampton

CH49 5PE

Arrowe Park Hospital, Upton

WN1 1RU

Thomas Linacre Centre, Wigan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

collaborator

Cancer Research UK

OTHER

lead

University of Birmingham

OTHER